We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

17 hedge funds and large institutions have $5.89M invested in Cumberland Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $5.62M → $5.89M (+$273K)

1.65% less ownership

Funds ownership: 18.34% → 16.69% (-1.7%)

23% less funds holding

Funds holding: 22 → 17 (-5)

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 5

Holders
17
Holders Change
-5
Holders Change %
-22.73%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$24.1K
2
BlackRock
BlackRock
New York
+$240

Top Sellers

Rank Fund Capital Flow
1
BAM
Berkshire Asset Management
Pennsylvania
-$392K
2
Renaissance Technologies
Renaissance Technologies
New York
-$59.7K
3
SFP
Sterling Financial Planning
New Jersey
-$46K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$23.3K
5
Millennium Management
Millennium Management
New York
-$22K
Name Holding Trade Value Shares
Change 		Change in
Stake
Dimensional Fund Advisors
1
Dimensional Fund Advisors
Texas
$1.5M -$7.84K -3,333 -0.5%
Renaissance Technologies
2
Renaissance Technologies
New York
$1.44M -$59.7K -25,365 -4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$903K – – –
BCM
4
Bridgeway Capital Management
Texas
$691K – – –
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$451K – – –
BlackRock
6
BlackRock
New York
$338K +$240 +102 +0.1%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$180K – – –
Two Sigma Investments
8
Two Sigma Investments
New York
$109K -$14.8K -6,287 -12%
State Street
9
State Street
Massachusetts
$104K – – –
Two Sigma Advisers
10
Two Sigma Advisers
New York
$60K -$23.3K -9,892 -29%
Northern Trust
11
Northern Trust
Illinois
$45K – – –
Morgan Stanley
12
Morgan Stanley
New York
$31K +$24.1K +10,234 +385%
Prudential Financial
13
Prudential Financial
New Jersey
$25K – – –
TRCT
14
Tower Research Capital (TRC)
New York
$9K -$3.22K -1,367 -28%
OC
15
Oakworth Capital
Alabama
$7K – – –
BAM
16
Berkshire Asset Management
Pennsylvania
– -$392K -189,048 Closed
SFP
17
Sterling Financial Planning
New Jersey
– -$46K -22,031 Closed
Millennium Management
18
Millennium Management
New York
– -$22K -10,835 Closed
UBS Group
19
UBS Group
Switzerland
– -$8K -3,783 Closed
Bank of America
20
Bank of America
North Carolina
– -$1K -579 Closed
Wells Fargo
21
Wells Fargo
California
– -$2 -1 -2%

CPIX Hedge Fund Activity: Q3 2022 in Review

17 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q3 2022, worth a combined $5.89M — up 4.9% from $5.62M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of CPIX and 0 opened new positions — a net loss of 5 holders — while 6 trimmed existing stakes and 2 added.

The largest buyer was Morgan Stanley, adding an estimated $24.1K. The largest seller was Berkshire Asset Management, exiting entirely with an estimated $392K sold.

  • 17 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q3 2022, down from 22 in Q2 2022.
  • Funds reported $5.89M of Cumberland Pharmaceuticals stock for Q3 2022, up 4.9% quarter-over-quarter.
  • 0 funds opened new Cumberland Pharmaceuticals positions in Q3 2022 and 5 closed out, a net change of -5 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q3 2022 was Morgan Stanley, an estimated $24.1K added.
  • The largest Cumberland Pharmaceuticals seller in Q3 2022 was Berkshire Asset Management, an estimated $392K sold.

Based on aggregated 13F filings for Q3 2022.